Literature DB >> 22050887

PET imaging using 64Cu-labeled sulfophthalocyanines: synthesis and biodistribution.

Elena R Ranyuk1, Nicole Cauchon, Hasrat Ali, Roger Lecomte, Brigitte Guérin, Johan E van Lier.   

Abstract

Sulfonated metallo phthalocyanines (MPcS(n)) are second generation photosensitizers advanced for photodynamic therapy of various medical applications. A series of ZnPcS(n) was demetallated and subsequently converted to the corresponding [(64)Cu]CuPcS(n) in 40-50% isolated yields and >98% radiochemical purities. Tumor-bearing mice were injected with the (64)Cu-labeled products and subjected to 3-h dynamic PET imaging studies. Biodistribution patterns showed characteristic differences between the various derivatives. Tumor uptake was detected only for the amphiphilic derivatives [(64)Cu]CuPcS(2) and [(64)Cu]CuPcS(3)C(6) (1-1.5%ID/g). The biological data suggest that PET imaging with [(64)Cu]CuPc can be used to establish structure-PDT efficacy relationships for Pc-based photosensitizers.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22050887     DOI: 10.1016/j.bmcl.2011.09.121

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Carbohydrate based biomarkers enable hybrid near infrared fluorescence and 64Cu based radio-guidance for improved surgical precision.

Authors:  Wenbo Wang; Anders E Hansen; Hongmei Sun; Frederikke P Fliedner; Andreas Kjaer; Andreas I Jensen; Thomas L Andresen; Jonas R Henriksen
Journal:  Nanotheranostics       Date:  2021-05-17

Review 2.  Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development.

Authors:  Uwe Seibold; Björn Wängler; Ralf Schirrmacher; Carmen Wängler
Journal:  Biomed Res Int       Date:  2014-04-16       Impact factor: 3.411

Review 3.  Recent Advances in Photosensitizers as Multifunctional Theranostic Agents for Imaging-Guided Photodynamic Therapy of Cancer.

Authors:  Paromita Sarbadhikary; Blassan P George; Heidi Abrahamse
Journal:  Theranostics       Date:  2021-08-26       Impact factor: 11.556

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.